The activation of TAS2R4 and TAS2R14 by quinine or apigenin led to a significant concentration-dependent reduction in cell proliferation of the breast cancer cell line MDA-MB-231, while proliferation of MCF-10A, the normal breast epithelial cells, was only attenuated at higher ligand concentrations [17]. This evidence concerns the gene TAS2R14 and breast carcinoma.